Role of Statin Therapy in Prevention of Anthracycline-Induced Cardiotoxicity

Inclusion Criteria: * Female patients diagnosed with histology proven breast cancer with an indication to primary systemic therapy or adjuvant regimens based on anthracyclines Exclusion Criteria: * Patients with impaired LV systolic function (EF below 50%) * Patients with severe valvular heart disease * Patients previously diagnosed with coronary artery disease * Patients with baseline elevated liver enzymes * Patients with prior chemotherapy or radiation therapy * Pregnant females